AMP German Cannabis Group receives an import license for medical cannabis

AMP German Cannabis Group receives an import license for medical cannabis

AMP German Cannabis Group Inc. (“AMP”) (CSE:XCX) has received an import license from the Thuringian State Office. The license covers cannabis products for medical purposes. This is an important milestone for the German company and is another sign of the rising importance of the European cannabis market for cannabis producers and investors alike. AMP German Cannabis Group Inc. (AMP) (CSE: XCX), has announced that the Thuringian State Office for Consumer Protection (TLV) has granted Alternative Medical Products GmbH (AMP Deutschland), a wholly-owned subsidiary of AMP, a license to import cannabis products for medical use in Germany in accordance with Section 72 of the German Medicines Act (AMG). The TLV is responsible for all fundamental matters of consumer protection and its guidelines in the Free State of Thuringia. The hemp.im app offers opportunities for cannabis investors to keep up to date with the latest happenings in the cannabis sector. The app curates cannabis news from across the world and distills it to 400 characters or less, helping you remain informed no matter where you are or how much time you have. Medical cannabis import The import license offers AMP the possibility to import medical cannabis purchased outside the European Union into Germany. Immediately after importation…

Excerpt only …
READ MORE BELOW
Source : CANNANNEW REPORT
Link to original : AMP German Cannabis Group receives an import license for medical cannabis
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.